Matthew Laughon, Carl Bose, Elizabeth Allred, T Michael O’Shea, Linda J Van Marter, Francis Bednarek, Alan Leviton, ELGAN Study Investigators
The goals to ID the BP of ELGANs that prompt intervention & to ID other infant characteristics of BP therapies. At each GA, the lowest MAP in treated and untreated infants tended to increase with advancing postnatal age. The proportion of infants receiving any tx decreased with increasing GA from 93% at 23 wks to 73% at 27 wks. Lower GA lower B Wt ,male sex, and higher SNAP-II values associated with tx.